ArticleBritish journal of haematology2017

Rationale for combinatory chronic lymphocytic leukaemia treatment paradigms in the era of the B-cell receptor pathway and anti-apoptotic inhibitors: how do we mix, match, and move forward?

No numbers read from the abstract.

Not cited yet